WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

Market Cap	111.69B
Revenue (ttm)	102.11B
Net Income (ttm)	6.26B
Shares Out	13.20M
EPS (ttm)	473.76
PE Ratio	17.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	382,496
Average Volume	1,647,917
Open	8,430.00
Previous Close	8,430.00
Day's Range	8,350.00 - 8,610.00
52-Week Range	5,720.00 - 11,130.00
Beta	0.78
RSI	58.77
Earnings Date	n/a

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name...

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 330350

Financial Performance

In 2024, KOSDAQ:330350's revenue was 102.72 billion, an increase of 28.21% compared to the previous year's 80.12 billion. Earnings were 4.78 billion, a decrease of -39.88%.